Datavault AI Inc. (NASDAQ: DVLT) has announced a binding term sheet with Wellgistics Health (NASDAQ: WGRX) to create DelivMeds AI, a healthcare platform that integrates AI-driven pharmacy optimization, blockchain-enabled smart contracts, biometric verification, and direct-to-consumer healthcare delivery. The venture is structured through three concurrent transactions: an expanded PharmacyChain license, acquisition of QOLPOM intellectual property, and a controlling stake in Tollo Health. Combined, these transactions carry an expected approximate asset value of $4 billion, subject to an independent fairness opinion, and are intended to support a national rollout of data-driven healthcare delivery and patient engagement solutions.
DelivMeds AI aims to leverage Datavault's expertise in AI and data monetization alongside Wellgistics' healthcare infrastructure. The platform is designed to streamline pharmacy operations, enhance patient engagement, and ensure secure, verifiable transactions through blockchain technology. The inclusion of biometric verification adds a layer of security and personalization, potentially reducing fraud and improving patient trust. The direct-to-consumer delivery model could expand access to medications and healthcare services, particularly for underserved populations.
This announcement marks a significant step for both companies in the rapidly evolving healthcare technology sector. For Datavault AI, which is known for its work in AI-driven data experiences and asset monetization in the Web 3.0 environment, this venture represents a major expansion into healthcare. The company's technology suite includes AI- and machine-learning-based automation, third-party integration, and detailed analytics, which can be applied to optimize healthcare delivery. Wellgistics Health brings its pharmacy network and healthcare logistics expertise, making the partnership complementary.
The $4 billion asset value underscores the scale of the venture and the potential market opportunity. The national rollout could position DelivMeds AI as a key player in the transformation of pharmacy and healthcare delivery, especially as the industry increasingly adopts digital solutions. However, the venture is subject to an independent fairness opinion and other customary conditions, and the timeline for implementation has not been disclosed.
Datavault AI is headquartered in Philadelphia, PA, and its technologies include the WiSA, ADIO, and Sumerian brands for acoustic sciences, as well as the Information Data Exchange for digital twins and secure asset licensing. Wellgistics Health operates in the healthcare sector, focusing on pharmacy and health services. The collaboration is expected to combine these strengths to create a comprehensive healthcare platform.
For more information about Datavault AI, visit www.dvlt.ai. The latest news and updates relating to DVLT are available in the company’s newsroom at https://ibn.fm/DVLT.
